Indeed, lentiviral delivery of beclin 1 in a mouse model of Parkinson’s Disease was shown to protect against the loss of neuronal markers [51], and in an AD model reduced amyloid pathology [6]. This evidence concerns the gene BECN1 and amyloidosis.